AP2384A - 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
AP2384A
AP2384A AP2008004589A AP2008004589A AP2384A AP 2384 A AP2384 A AP 2384A AP 2008004589 A AP2008004589 A AP 2008004589A AP 2008004589 A AP2008004589 A AP 2008004589A AP 2384 A AP2384 A AP 2384A
Authority
AP
ARIPO
Prior art keywords
tetrahydro
preparation
pharmaceutical compositions
compositions containing
benzazepine compounds
Prior art date
Application number
AP2008004589A
Other languages
English (en)
Other versions
AP2008004589A0 (en
Inventor
Jean-Louis Peglion
Bertrand Goument
Aimce Dessinges
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39323822&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2384(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2008004589A0 publication Critical patent/AP2008004589A0/xx
Application granted granted Critical
Publication of AP2384A publication Critical patent/AP2384A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
AP2008004589A 2007-09-11 2008-08-26 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. AP2384A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706346A FR2920773B1 (fr) 2007-09-11 2007-09-11 Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
AP2008004589A0 AP2008004589A0 (en) 2008-08-31
AP2384A true AP2384A (en) 2012-03-21

Family

ID=39323822

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004589A AP2384A (en) 2007-09-11 2008-08-26 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (45)

Country Link
US (1) US8076325B2 (xx)
EP (1) EP2036892B1 (xx)
JP (1) JP4932805B2 (xx)
KR (1) KR101078076B1 (xx)
CN (1) CN101386594B (xx)
AP (1) AP2384A (xx)
AR (1) AR068386A1 (xx)
AT (1) ATE460401T1 (xx)
AU (1) AU2008207585B2 (xx)
BR (1) BRPI0804091B8 (xx)
CA (1) CA2639349C (xx)
CL (1) CL2008002654A1 (xx)
CO (1) CO6020016A1 (xx)
CR (1) CR10229A (xx)
CU (1) CU23706B7 (xx)
CY (1) CY1110034T1 (xx)
DE (1) DE602008000786D1 (xx)
DK (1) DK2036892T3 (xx)
EA (1) EA014756B1 (xx)
EC (1) ECSP088731A (xx)
ES (1) ES2342511T3 (xx)
FR (1) FR2920773B1 (xx)
HK (1) HK1129667A1 (xx)
HN (1) HN2008001393A (xx)
HR (1) HRP20100259T1 (xx)
JO (1) JO2652B1 (xx)
MA (1) MA30315B1 (xx)
ME (1) ME00981B (xx)
MX (1) MX2008011164A (xx)
MY (1) MY143079A (xx)
NI (1) NI200800247A (xx)
NZ (1) NZ571143A (xx)
PA (1) PA8795301A1 (xx)
PE (1) PE20090620A1 (xx)
PL (1) PL2036892T3 (xx)
PT (1) PT2036892E (xx)
RS (1) RS51305B (xx)
SA (1) SA08290567B1 (xx)
SG (1) SG151172A1 (xx)
SI (1) SI2036892T1 (xx)
TW (1) TWI374029B (xx)
UA (1) UA100003C2 (xx)
UY (1) UY31305A1 (xx)
WO (1) WO2009066041A2 (xx)
ZA (1) ZA200807586B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
TWI654180B (zh) 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
US9333208B2 (en) 2013-07-16 2016-05-10 Movses H. Karakossian HCN inhibitors affecting ganglion cell function and visual function
FR3020810B1 (fr) * 2014-05-06 2016-05-06 Servier Lab Nouveau sel de l'ivabradine et son procede de preparation.
FR3046793B1 (fr) * 2016-01-14 2018-01-05 Les Laboratoires Servier Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20230140818A1 (en) * 2017-04-27 2023-05-04 The University Of Hong Kong Use of hcn inhibitors for treatment of cancer
CN112724001B (zh) * 2019-10-28 2022-12-13 鲁南制药集团股份有限公司 一种伊伐布雷定手性中间体化合物
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv
EP4361143A1 (en) 2021-08-31 2024-05-01 Eisai R&D Management Co., Ltd. Method for producing monocyclic pyridine derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161604A2 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae GmbH Neue Aminotetralinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0534859A1 (fr) * 1991-09-27 1993-03-31 Adir Et Compagnie 3-Benzazépin-zones substituées par un groupe benzocyclobutyl- ou indanyl-alkyl-amino-alkyle, utiles dans le traitement des affections cardiovasculaires
WO2006092491A1 (fr) * 2005-02-28 2006-09-08 Les Laboratoires Servier FORME CRISTALLINE βd DU CHLORHYDRATE DE L'IVABRADINE, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
JPH02193971A (ja) * 1989-01-20 1990-07-31 Yamanouchi Pharmaceut Co Ltd トリ置換―２，３，４，５―テトラヒドロベンズアゼピン誘導体とその中間体
EP0700389A1 (en) * 1993-05-27 1996-03-13 Smithkline Beecham Laboratoires Pharmaceutiques Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
TW527355B (en) * 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
US6514964B1 (en) * 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
FR2894826B1 (fr) 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161604A2 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae GmbH Neue Aminotetralinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0534859A1 (fr) * 1991-09-27 1993-03-31 Adir Et Compagnie 3-Benzazépin-zones substituées par un groupe benzocyclobutyl- ou indanyl-alkyl-amino-alkyle, utiles dans le traitement des affections cardiovasculaires
WO2006092491A1 (fr) * 2005-02-28 2006-09-08 Les Laboratoires Servier FORME CRISTALLINE βd DU CHLORHYDRATE DE L'IVABRADINE, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Also Published As

Publication number Publication date
TWI374029B (en) 2012-10-11
JP4932805B2 (ja) 2012-05-16
PA8795301A1 (es) 2009-04-23
HRP20100259T1 (hr) 2010-06-30
EP2036892A1 (fr) 2009-03-18
US20090069296A1 (en) 2009-03-12
ME00981B (me) 2012-06-20
SI2036892T1 (sl) 2010-06-30
ES2342511T3 (es) 2010-07-07
CN101386594A (zh) 2009-03-18
CN101386594B (zh) 2012-05-16
FR2920773A1 (fr) 2009-03-13
FR2920773B1 (fr) 2009-10-23
MA30315B1 (fr) 2009-04-01
CL2008002654A1 (es) 2009-03-20
CR10229A (es) 2008-11-26
JP2009108032A (ja) 2009-05-21
WO2009066041A2 (fr) 2009-05-28
RS51305B (sr) 2010-12-31
CU23706B7 (es) 2011-10-05
CY1110034T1 (el) 2015-01-14
PE20090620A1 (es) 2009-05-30
UA100003C2 (ru) 2012-11-12
CO6020016A1 (es) 2009-03-31
MX2008011164A (es) 2009-03-10
BRPI0804091B1 (pt) 2020-09-29
KR101078076B1 (ko) 2011-10-28
KR20090027164A (ko) 2009-03-16
AP2008004589A0 (en) 2008-08-31
PL2036892T3 (pl) 2010-08-31
TW200918076A (en) 2009-05-01
US8076325B2 (en) 2011-12-13
SA08290567B1 (ar) 2011-06-22
EP2036892B1 (fr) 2010-03-10
AU2008207585A1 (en) 2009-03-26
HK1129667A1 (xx) 2009-12-04
AR068386A1 (es) 2009-11-11
HN2008001393A (es) 2011-05-11
MY143079A (en) 2011-02-28
ATE460401T1 (de) 2010-03-15
UY31305A1 (es) 2008-10-31
NZ571143A (en) 2010-04-30
EA200801828A2 (ru) 2009-04-28
JO2652B1 (en) 2012-06-17
ZA200807586B (en) 2011-04-28
EA200801828A3 (ru) 2009-08-28
WO2009066041A3 (fr) 2009-12-17
CA2639349A1 (fr) 2009-03-11
DK2036892T3 (da) 2010-06-07
ECSP088731A (es) 2008-10-31
CA2639349C (fr) 2011-03-22
SG151172A1 (en) 2009-04-30
BRPI0804091A2 (pt) 2009-05-05
NI200800247A (es) 2011-01-10
DE602008000786D1 (de) 2010-04-22
BRPI0804091B8 (pt) 2021-05-25
PT2036892E (pt) 2010-05-10
AU2008207585B2 (en) 2013-08-22
CU20080165A7 (es) 2011-03-21
EA014756B1 (ru) 2011-02-28

Similar Documents

Publication Publication Date Title
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200704957B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL184562A (en) Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it
IL200128A0 (en) New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HK1096386A1 (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
IL193774A0 (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
ZA200603810B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
HK1096097A1 (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1093986A1 (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704955B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA200800833B (en) New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200606276B (en) Polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200606277B (en) Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA200805656B (en) Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
ZA201203943B (en) New azabicyclo[3.1.0]hex-2-yl compounds,a process for their preparation and pharmaceutical compositions containing them
AP2010005327A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them.
AP2755A (en) New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
HK1119163A1 (en) Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them